HOUSE BILL 1246
J5 5lr3479
HB 879/24 – HGO
By: Delegate S. Johnson Delegates S. Johnson, Alston, Bagnall, Bhandari,
Cullison, Guzzone, Hill, Kaiser, Kerr, Kipke, Lopez, Martinez, Pena–Melnyk,
Rosenberg, Ross, Taveras, White Holland, Woods, and Woorman
Introduced and read first time: February 7, 2025
Assigned to: Health and Government Operations
Committee Report: Favorable with amendments
House action: Adopted
Read second time: March 1, 2025
CHAPTER ______
1 AN ACT concerning
2 Health Benefit Plans – Calculation of Cost–Sharing Contribution –
3 Requirements
4 FOR the purpose of requiring certain insurers, nonprofit health service plans, and health
5 maintenance organizations to include certain discounts, financial assistance
6 payments, product vouchers, and other out–of–pocket expenses made by or on behalf
7 of an insured or enrollee when calculating certain cost–sharing contributions for
8 certain prescription drugs; requiring certain persons that provide certain discounts,
9 financial assistance payments, product vouchers, or other out–of–pocket expenses to
10 notify an insured or enrollee of certain information and to provide the discount,
11 financial assistance payment, product voucher, or other out–of–pocket expense for a
12 certain period of time; prohibiting certain insurers, nonprofit health service plans,
13 and health maintenance organizations from setting, altering, implementing, or
14 conditioning the terms of certain coverage based on the availability or amount of
15 financial or product assistance available for a prescription drug; providing that a
16 violation of a certain provision of this Act is considered a violation of the Consumer
17 Protection Act; and generally relating to the calculation of cost sharing
18 requirements.
19 BY adding to
20 Article – Insurance
21 Section 15–118.1
22 Annotated Code of Maryland
EXPLANATION: CAPITALS INDICATE MATTER ADDED TO EXISTING LAW.
[Brackets] indicate matter deleted from existing law.
Underlining indicates amendments to bill.
Strike out indicates matter stricken from the bill by amendment or deleted from the law by
amendment. *hb1246*

2 HOUSE BILL 1246
1 (2017 Replacement Volume and 2024 Supplement)
2 SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF MARYLAND,
3 That the Laws of Maryland read as follows:
4 Article – Insurance
5 15–118.1.
6 (A) (1) THIS SECTION APPLIES TO:
7 (I) INSURERS AND NONPROFIT HEALTH SERVICE PLANS THAT
8 PROVIDE HOSPITAL, MEDICAL, OR SURGICAL BENEFITS TO INDIVIDUALS OR GROUPS
9 ON AN EXPENSE–INCURRED BASIS UNDER HEALTH INSURANCE POLICIES OR
10 CONTRACTS THAT ARE ISSUED OR DELIVERED IN THE STATE; AND
11 (II) HEALTH MAINTENANCE ORGANIZATIONS THAT PROVIDE
12 HOSPITAL, MEDICAL, OR SURGICAL BENEFITS TO INDIVIDUALS OR GROUPS UNDER
13 CONTRACTS THAT ARE ISSUED OR DELIVERED IN THE STATE.
14 (2) AN INSURER, A NONPROFIT HEALTH SERVICE PLAN, OR A HEALTH
15 MAINTENANCE ORGANIZATION THAT PROVIDES COVERAGE FOR PRESCRIPTION
16 DRUGS THROUGH A PHARMACY BENEFITS MANAGER IS SUBJECT TO THE
17 REQUIREMENTS OF THIS SECTION.
18 (B) (1) SUBJECT TO PARAGRAPH (2) OF THIS SUBSECTION, WHEN
19 CALCULATING AN INSURED’S OR ENROLLEE’S CONTRIBUTION TO THE INSURED’S OR
20 ENROLLEE’S COINSURANCE, COPAYMENT, DEDUCTIBLE, OR OUT–OF–POCKET
21 MAXIMUM UNDER THE INSURED’S OR ENROLLEE’S HEALTH BENEFIT PLAN, AN
22 ENTITY SUBJECT TO THIS SECTION SHALL INCLUDE ANY DISCOUNT, FINANCIAL
23 ASSISTANCE PAYMENT, PRODUCT VOUCHER, OR OTHER OUT–OF–POCKET EXPENSE
24 MADE BY OR ON BEHALF OF THE INSURED OR ENROLLEE FOR A PRESCRIPTION
25 DRUG:
26 (I) THAT IS COVERED UNDER THE INSURED’S OR ENROLLEE’S
27 HEALTH BENEFIT PLAN; AND
28 (II) 1. THAT DOES NOT HAVE AN AB–RATED GENERIC
29 EQUIVALENT DRUG OR AN INTERCHANGEABLE BIOLOGICAL PRODUCT PREFERRED
30 UNDER THE HEALTH BENEFIT PLAN’S FORMULARY; OR
31 2. A. THAT HAS AN AB–RATED GENERIC
32 EQUIVALENT DRUG OR AN INTERCHANGEABLE BIOLOGICAL PRODUCT PREFERRED
33 UNDER THE HEALTH BENEFIT PLAN’S FORMULARY; AND

HOUSE BILL 1246 3
1 B. FOR WHICH THE INSURED OR ENROLLEE ORIGINALLY
2 OBTAINED COVERAGE THROUGH PRIOR AUTHORIZATION, A STEP THERAPY
3 PROTOCOL, OR THE EXCEPTION OR APPEAL PROCESS OF THE ENTITY SUBJECT TO
4 THIS SECTION.
5 (2) IF AN INSURED OR ENROLLEE IS COVERED UNDER A
6 HIGH–DEDUCTIBLE HEALTH PLAN, AS DEFINED IN 26 U.S.C. § 223, THIS
7 SUBSECTION DOES NOT APPLY TO THE DEDUCTIBLE REQUIREMENT OF THE
8 HIGH–DEDUCTIBLE HEALTH PLAN.
9 (C) (1) A EXCEPT AS PROVIDED IN PARAGRAPH (3) OF THIS SUBSECTION,
10 A PERSON THAT PROVIDES A DISCOUNT, FINANCIAL ASSISTANCE PAYMENT,
11 PRODUCT VOUCHER, OR OTHER OUT–OF–POCKET EXPENSE MADE BY OR ON BEHALF
12 OF THE INSURED OR ENROLLEE THAT IS USED IN THE CALCULATION OF THE
13 INSURED’S OR ENROLLEE’S CONTRIBUTION TO THE INSURED’S OR ENROLLEE’S
14 COINSURANCE, COPAYMENT, DEDUCTIBLE, OR OUT–OF–POCKET MAXIMUM SHALL:
15 (I) WITHIN 7 DAYS AFTER THE ACCEPTANCE OF THE DISCOUNT,
16 FINANCIAL ASSISTANCE PAYMENT, PRODUCT VOUCHER, OR OTHER
17 OUT–OF–POCKET EXPENSE, NOTIFY THE INSURED OR ENROLLEE OF:
18 (I) 1. THE MAXIMUM DOLLAR AMOUNT OF THE DISCOUNT,
19 FINANCIAL ASSISTANCE PAYMENT, PRODUCT VOUCHER, OR OTHER
20 OUT–OF–POCKET EXPENSE; AND
21 (II) 2. THE EXPIRATION DATE FOR THE DISCOUNT,
22 FINANCIAL ASSISTANCE PAYMENT, PRODUCT VOUCHER, OR OTHER
23 OUT–OF–POCKET EXPENSE; AND
24 (II) PROVIDE THE DISCOUNT, FINANCIAL ASSISTANCE
25 PAYMENT, PRODUCT VOUCHER, OR OTHER OUT–OF–POCKET EXPENSE FOR THE
26 DURATION OF THE PLAN YEAR.
27 (2) A VIOLATION OF PARAGRAPH (1) OF THIS SUBSECTION IS A
28 VIOLATION OF THE CONSUMER PROTECTION ACT.
29 (3) THIS SUBSECTION DOES NOT APPLY TO A CHARITABLE
30 ORGANIZATION THAT PROVIDES A DISCOUNT, FINANCIAL ASSISTANCE PAYMENT,
31 PRODUCT VOUCHER, OR OTHER OUT–OF–POCKET EXPENSE TO AN INSURED OR
32 ENROLLEE.
33 (D) (1) SUBJECT TO PARAGRAPH (2) OF THIS SUBSECTION, AN ENTITY
34 SUBJECT TO THIS SECTION MAY NOT DIRECTLY OR INDIRECTLY SET, ALTER,
35 IMPLEMENT, OR CONDITION THE TERMS OF HEALTH BENEFIT PLAN COVERAGE,

4 HOUSE BILL 1246
1 INCLUDING THE BENEFIT DESIGN, BASED IN WHOLE OR IN PART ON INFORMATION
2 ABOUT THE AVAILABILITY OR AMOUNT OF FINANCIAL OR PRODUCT ASSISTANCE
3 AVAILABLE FOR A PRESCRIPTION DRUG.
4 (2) PARAGRAPH (1) OF THIS SUBSECTION MAY NOT BE CONSTRUED
5 TO PROHIBIT AN ENTITY SUBJECT TO THIS SECTION FROM USING REBATES IN THE
6 DESIGN OF PRESCRIPTION DRUG COVERAGE OR BENEFITS.
7 SECTION 2. AND BE IT FURTHER ENACTED, That this Act shall apply to all
8 policies, contracts, and health plans issued, delivered, or renewed in the State on or after
9 January 1, 2026.
10 SECTION 3. AND BE IT FURTHER ENACTED, That this Act shall take effect
11 January 1, 2026.
Approved:
________________________________________________________________________________
Governor.
________________________________________________________________________________
Speaker of the House of Delegates.
________________________________________________________________________________
President of the Senate.

[DELETED: :CA      5     D S D S A B B A H R F m o t i c d f a p o c f n a i o e o c i a t p t d f c a h m o f s a i o c f v P A a g r t t c o c s r B  A S  A]
[DELETED:  H   (  S T A    )()TH    IL L   A EEI B U H I P O TE      IH M O T PL L  T    )A,R N  O T P C F P T A P B M I S T T    )()S()U T P  O T SN WDSESDS’ES CE CT DE O OTOFP,,,– U T IDS O EES H B PN A’ S T T S S I A DT FT R TOFP,– B O O B O T I O E F A P     )’TDSESN       )1.AIT D N H A R GNSY        .A.A H A R GNSY  ]
[DELETED: H 3      C T P AN A S TL     )I A I O E I C U AHD H PN A D I     T,26U.§2 D N A T T D R O THD    )()AE() X  NP T P A DT F A PT R TOFPRO–  T I O E T I U I T C O TDS O EES C T T IDS O EES’’E T E TOFP,,––     )7W  T A PT P VR O O,TOFPEN–,       )1.TT A PT P VR O O,TOFPE –     ) 2.IT E D F T DT A PT P VR O O,TOFPE –     )IP T DT F AT P VR O O OTOFP E F T,–    )A(V O P  O T S I A O R CPA  ()  S D N A T A C T P A DT F A PT VR O O OTOFP E T A I O–    )()S()U P  O T SN A E T T S M N D O I ST ART O C T T O H B P CE]
[DELETED:  H N  T A O A O F O P A    )P(     S p J  S A B I F E T t A s t e J          G               ]